How brain cells push out toxic protein clumps in Alzheimer's

Molecular and Cell Biological Foundations of Proteostress-Induced Neuronal Extrusion

['FUNDING_R01'] · RUTGERS, THE STATE UNIV OF N.J. · NIH-11311290

Using tiny transparent worms, researchers are learning how stressed brain cells push out toxic protein clumps that may spread in Alzheimer's disease.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorRUTGERS, THE STATE UNIV OF N.J. (nih funded)
Locations1 site (PISCATAWAY, UNITED STATES)
Trial IDNIH-11311290 on ClinicalTrials.gov

What this research studies

This project uses tiny transparent worms (C. elegans) so scientists can watch single neurons in real time and see how they form large vesicles called exophers that carry damaged proteins. Researchers put human Alzheimer's-related proteins into those neurons and use genetics and live imaging to see when and why exophers form. They manipulate protein quality-control systems (like the proteasome) and cellular structures (such as actin and actomyosin) to understand what drives extrusion of toxic material. The goal is to map the cell-level steps that let harmful protein aggregates leave neurons and move through tissues.

Who could benefit from this research

Good fit: There is no patient enrollment for this lab-based work, but the findings are most relevant to adults with Alzheimer's disease and may inform future clinical trials they could join.

Not a fit: Because this is basic laboratory research in worms, patients should not expect direct or immediate clinical benefit from this project.

Why it matters

Potential benefit: If successful, this work could reveal new ways to stop the spread of toxic proteins and guide therapies that protect neurons in Alzheimer's disease.

How similar studies have performed: Previous lab studies have shown neurons can eject exophers in worms and that these can carry protein aggregates, but translating these findings to humans remains early and largely untested.

Where this research is happening

PISCATAWAY, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.